The latest research from ASCO at the Living Room Series
On 15 June the GI Cancer Institute held an instalment of the Living Room Series in Sydney. Two... Read More
AGITG News: January-June 2020
Our trials during COVID-19 While many of us have been working from home, there has certainly been a lot of work to do in light of the pandemic. The impact of the COVID-19 pandemic on the AGITG-CTC (NHMRC Clinical Trials Centre) trials portfolio is being reviewed on an ongoing basis as... Read More
Welcome to Dr Lorraine Chantrill, new AGITG Chair
On 15 May 2020, the AGITG welcomed Dr Lorraine Chantrill as the new Chair of the organisation. Dr... Read More
Group Coordinator trial update May 2020
While many of us have been working from home, there has certainly been a lot of work to... Read More
May 2020: AGITG Trial Updates
SSGXXII approved by the Upper GI Working Party The SSGXXII trial concept was approved by the Upper GI Working... Read More
AGITG Trial News
AGITG Trial news: The AGITG currently has fourteen studies open to recruitment and three studies in... Read More
Our Future Trials
The GI Cancer Institute has four trials in development, unlocking new treatments for people with GI cancer. RoLaCaRT-1 Using a... Read More
The future of the GI Cancer Institute
A message from Dr Lorraine Chantrill, Chair of the GI Cancer Institute. Personally, I have a very strong family... Read More
Final patient joins the MODULATE clinical trial
The final patient participating in the MODULATE clinical trial has now joined, meaning that... Read More
COVID-19 April update
As the COVID-19 pandemic continues to evolve, we are also continuing to evolve the way we work –... Read More
Ruth Henwood creates a legacy to give hope to the future
Ruth’s Bequest is in memory of her late husband, Lance, who passed away from oesophageal cancer in 2013. Lance’s... Read More